Skip to main content
SpringerLink
Log in

Clinical Study on the Relationship Between Hematocytopenia and Splenomegaly Caused by Cirrhotic Portal Hypertension

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

This clinical study was designed to evaluate the presence of hematocytopenia in patients with splenomegaly caused by non-alcoholic cirrhotic portal hypertension. For this purpose, we randomly selected 358 patients with splenomegaly caused by non-alcoholic cirrhotic portal hypertension and admitted to the clinical data in our hospital between January 1991 and June 2009. Among these 358 patients, 322 patients (90.0 %) showed hematocytopenia, including multi-hemocyte decrease in 206 patients (i.e., 89 patients with a decrease in white blood cell count (WBC) + red blood cell count (RBC) + platelets count (PLT)); 52 patients with WBC + PLT decrease; 29 patients with RBC + PLT decrease; and 36 patients with WBC + RBC decrease) and single-hemocyte decrease in 116 patients (i.e., 31 cases with single PLT decrease; 29 cases with single WBC decrease; and 56 patients with single RBC decrease). After splenectomy, 36 patients (10.0 %) with hematocytopenia presented a statistical improvement of blood cell to normal level (P < 0.05), while 32 patients did not have any change as compared to pre-operative one (P > 0.05). It has to be noted that 4 patients did not received any surgery. Hematocytopenia was not detected in all the patients with splenomegaly caused by cirrhotic portal hypertension, thus it is probably a complication of splenomegaly but not an inevitable manifestation. It was concluded that splenectomy could be an effective treatment for splenomegaly associated with hematocytopenia, but patients without hematocytopenia could choose a non-surgical alternative treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wu, Z., & Wu, Z. (2008). Surgery 7th edit. Beijing: People’s Medical Publishing House. ISBN978-7-117-09621-8R.9622.p525-532.

    Google Scholar 

  2. Koike, Y., Yoneyama, A., Shirai, J., Ishida, T., Shoda, E., Miyazaki, K., et al. (1998). Evaluation of thrombopoiesis in thrombocytopenic disorders by simultaneous measurement of reticulated platelets of whole blood and serum thrombopoietin concentrations. Thrombosis and Haemostasis, 79, 1106–1110.

    CAS  PubMed  Google Scholar 

  3. Karasu, Z., Gurakar, A., Kerwin, B., Hulagu, S., Jazzar, A., McFadden, R., et al. (2000). Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis. Digestive Diseases and Sciences, 45, 1971–1976.

    Article  CAS  PubMed  Google Scholar 

  4. Bashour, F. N., Teran, J. C., & Mullen, K. D. (2000). Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease. American Journal of Gastroenterology, 95, 2936–2939. doi:10.1111/j.1572-0241.2000.02325.x.

    Article  CAS  PubMed  Google Scholar 

  5. Kalambokis, G., & Tsianos, E. V. (2011). Endotoxaemia in the pathogenesis of cytopenias in liver cirrhosis. Could oral antibiotics raise blood counts? Medical Hypotheses, 76, 105–109. doi:10.1016/j.mehy.2010.08.043.

    Article  CAS  PubMed  Google Scholar 

  6. Miura, H., Kondo, S., Shimada, T., Sugiura, H., Morikawa, T., Okushiba, S., et al. (1999). Long-term effects of distal splenorenal shunt with splenopancreatic and gastric disconnection on hypersplenism due to liver cirrhosis. Hepato-Gastroenterology, 46, 2995–2998.

    CAS  PubMed  Google Scholar 

  7. Tomikawa, M., Hashizume, M., Akahoshi, T., Shimabukuro, R., Gotoh, N., Ohta, M., et al. (2002). Effects of splenectomy on liver volume and prognosis of cirrhosis in patients with esophageal varices. Journal of Gastroenterology and Hepatology, 17, 77–80.

    Article  PubMed  Google Scholar 

  8. Sakai, T., Shiraki, K., Inoue, H., Sugimoto, K., Ohmori, S., Murata, K., et al. (2002). Complications of partial splenic embolization in cirrhotic patients. Digestive Diseases and Sciences, 47, 388–391.

    Article  PubMed  Google Scholar 

  9. Hashimoto, N., Akahoshi, T., Tomikawa, M., Kawanaka, H., Konishi, K., Uehara, H., et al. (2010). Value of laparoscopic splenectomy as salvage treatment for relapsed thrombocytopenia after partial splenic arterial embolization. Digestive Surgery, 27, 515–520. doi:10.1159/000320331.

    Article  PubMed  Google Scholar 

  10. Faeh, M., Hauser, S. P., & Nydegger, U. E. (2001). Transient thrombopoietin peak after liver transplantation for end-stage liver disease. British Journal of Haematology, 112, 493–498.

    Article  CAS  PubMed  Google Scholar 

  11. Rockey, D. C. (2001). Cellular pathophysiology of portal hypertension and prospects for management with gene therapy. Clinics in Liver Disease, 5, 851–865.

    Article  CAS  PubMed  Google Scholar 

  12. Zuchini, R., Huang, C. H., Tsai, H. W., Huang, S. C., Lin, C. P., Chen, C. Y., et al. (2010). Electromagnetic thermoablation to treat thrombocytopenia in cirrhotic and hypersplenic rats. Journal of Gastroenterology and Hepatology, 25, 1578–1586. doi:10.1111/j.1440-1746.2010.06266.x.

    Article  PubMed  Google Scholar 

  13. Doan, C. A. (1949). Hypersplenism. Bulletin of the New York Academy of Medicine, 25, 625–650.

    CAS  PubMed Central  PubMed  Google Scholar 

  14. Shah, S. H., Hayes, P. C., Allan, P. L., Nicoll, J., & Finlayson, N. D. (1996). Measurement of spleen size and its relation to hypersplenism and portal hemodynamics in portal hypertension due to hepatic cirrhosis. American Journal of Gastroenterology, 91, 2580–2583.

    CAS  PubMed  Google Scholar 

  15. Jiao, Y. F., Okumiya, T., Saibara, T., Kudo, Y., & Sugiura, T. (2001). Erythrocyte creatine as a marker of excessive erythrocyte destruction due to hypersplenism in patients with liver cirrhosis. Clinical Biochemistry, 34, 395–398.

    Article  CAS  PubMed  Google Scholar 

  16. Friedman, L. S. (1999). The risk of surgery in patients with liver disease. Hepatology, 29, 1617–1623. doi:10.1002/hep.510290639.

    Article  CAS  PubMed  Google Scholar 

  17. Zhou Y (2002) Modern Diagnostics & Therapeutics of Liver Cirrhosis. 1st edition. Chinese edition library CIP data checks a word No. 2865 (pp 247–249) Beijing: People’s Military Medical Press.

  18. Bruno, C. M., Neri, S., Sciacca, C., Bertino, G., Di Prima, P., Cilio, D., et al. (2004). Plasma erythropoietin levels in anaemic and non-anaemic patients with chronic liver diseases. World Journal of Gastroenterology, 10, 1353–1356.

    CAS  PubMed  Google Scholar 

  19. Priyadarshi, A., & Shapiro, J. I. (2006). Erythropoietin resistance in the treatment of the anemia of chronic renal failure. Seminars in Dialysis, 19, 273–278. doi:10.1111/j.1525-139X.2006.00172.x.

    Article  PubMed  Google Scholar 

  20. Kusaba, N., Kumashiro, R., Ogata, H., Sata, M., & Tanikawa, K. (1998). In vitro study of neutrophil apoptosis in liver cirrhosis. Internal Medicine, 37, 11–17.

    Article  CAS  PubMed  Google Scholar 

  21. Eissa, L. A., Gad, L. S., Rabie, A. M., & El-Gayar, A. M. (2008). Thrombopoietin level in patients with chronic liver diseases. Annals of Hematology, 7, 235–244.

    CAS  Google Scholar 

  22. Dusheiko, G. (2009). Thrombopoietin agonists for the treatment of thrombocytopenia in liver disease and hepatitis C. Clinics in Liver Disease, 13, 487–501. doi:10.1016/j.cld.2009.05.012.

    Article  PubMed  Google Scholar 

  23. Kawasaki, T., Takeshita, A., Souda, K., Kobayashi, Y., Kikuyama, M., Suzuki, F., et al. (1999). Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis. American Journal of Gastroenterology, 94, 1918–1922. doi:10.1111/j.1572-0241.1999.01231.x.

    Article  CAS  PubMed  Google Scholar 

  24. Wolber, E. M., Ganschow, R., Burdelski, M., & Jelkmann, W. (1999). Hepatic thrombopoietin mRNA levels in acute and chronic liver failure of childhood. Hepatology, 29, 1739–1742. doi:10.1002/hep.510290627.

    Article  CAS  PubMed  Google Scholar 

  25. Lv, Y., Qiu, Q., & Dong, Y. (2006). Effective evaluation of total splenectomy on portal-hypertensive hypersplenism due to cirrhosis. Chinese Journal of Clinical Medicine, 5(5), 8–10.

    Google Scholar 

  26. Yang, X., Ma, H., & Cai, Z. (2000). Efficacy of partial splenectomy on cirrhosis splenomegaly hypersplenism. Chinese Journal of Hepatobiliary Surgery, 6(5), 337–340.

    Google Scholar 

  27. Ichikawa, N., Kitano, K., Shimodaira, S., Ishida, F., Ito, T., Kajikawa, S., et al. (1998). Changes in serum thrombopoietin levels after splenectomy. Acta Haematologica, 100, 137–141. doi:http://www.ncbi.nlm.nih.gov/pubmed/9858790.

    Article  CAS  PubMed  Google Scholar 

  28. Lv, Y., & Chen, Y. (2006). Total splenectomy a treatment portal-hypertension hypersplenism. Chinese Journal of Clinical Surgery, 14(7), 413–414.

    Google Scholar 

  29. Lv, Y. (2009). Characteristics and clinical significance of hypersplenism secondary to splenomegaly caused by cirrhotic portal hypertension. Shijie Huaren Xiaohua Zazhi, 17(29), 2969–2971.

    Google Scholar 

  30. Chernykh, E. R., Starostina, N. M., Paltsev, A. I., Leplina, O. Y., Shevela, E. Y., Shipunov, M. V., et al. (2007). Autologous bone marrow cells in the treatment of cirrhosis of the liver. Bulletin of Experimental Biology and Medicine, 144, 640–645.

    Article  CAS  PubMed  Google Scholar 

  31. Lv, Y., Li, X., Xie, X., Gong, X., Tian, X., & Yang, Y. (2009). Portal hypertension splenomegaly is not always associated with hematocytopenia. Jounal of US–China, Medical Science, 6(1), 28–30.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Surgery Department, People’s Hospital of Hainan Province, Haikou, 570311, People’s Republic of China

    Yunfu Lv, Xiaoguang Gong, Xianhe Xie, Baochun Wang, Yijun Yang & Yejuan Li

Authors
  1. Yunfu Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiaoguang Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xianhe Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Baochun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yijun Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yejuan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiaoguang Gong.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lv, Y., Gong, X., Xie, X. et al. Clinical Study on the Relationship Between Hematocytopenia and Splenomegaly Caused by Cirrhotic Portal Hypertension. Cell Biochem Biophys 70, 355–360 (2014). https://doi.org/10.1007/s12013-014-9920-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-014-9920-9

Keywords

Search

Navigation